The largest database of trusted experimental protocols

3 protocols using percp anti mouse cd11c

1

Comprehensive Immune Profiling of Murine Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carprofen (Rimadyl® Injectable, 50 mg/mL) was purchased from Patterson Companies (Saint Paul, MN, USA). Pacific Blue™ anti-mouse CD3, FITC anti-mouse CD4, PerCP anti-mouse CD8a, PE anti-mouse/human CD11b, APC/Cy7 anti-mouse Ly-6G/Ly-6C (Gr-1), PE/Cy7 anti-mouse CD62L, APC anti-mouse/human CD44, APC anti-mouse CD25, Biolegend PE anti-mouse/rat/human FOXP3, PerCP anti-mouse CD11c, PE/Cy7 anti-mouse CD86, FITC anti-mouse I-A/I-E, and APC anti-mouse CD40 were purchased from Biolegend (San Diego, CA, USA). Mouse tumor dissociation kit (No. 130-096-730) was purchased from Miltenyi Biotec (Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
2

Enhancing CD8+ DC Presentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were subcutaneously injected with 5 mg CytC (Sigma-Aldrich) on each side of the tail base every 12 h for 4 injections in total. 24 h after the last injection, cell suspensions from the spleen and draining LNs were prepared to enrich DCs as described above. The enriched DCs were then stained with PerCP anti-mouse CD11c (clone: N418, BioLegend) and FITC anti-mouse CD8α (clone: 53–6.7, BioLegend) to determine the fraction of CD8+ DCs by flow cytometry. To detect the pOVA epitopes presentation in mice that were treated with CytC, iTEP-sMMP-pOVA was injected subcutaneously at one hour after the last injection of CytC. 24 h later, DCs from the mouse spleen and draining LNs were collected to do B3Z activation assay as described above.
+ Open protocol
+ Expand
3

Bone Marrow-Derived Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the maturation and activation status of BMDCs upon exposure to LMs and the three inhibitors, flow cytometry were carried out. Briefly, BMDCs were stained with a combination of antibodies (AF-700 anti-mouse MHCII [Biolegend, USA], PE-anti mouse CD86 [Biolegend, USA] and PerCP anti-mouse CD11c [Biolegend, USA]) on ice for 20 min. BMDCs were washed with staining buffer (3% fetal bovine serum in 1X PBS) to block any nonspecific antibody binding, resuspended in PBS in the dark on ice for 30 min before acquisition by Flow Cytometer FACS CANTO II. BMDCs were acquired with FACS Diva™ software from BD Biosciences (New Jersey, USA) and analyzed by FlowJo ® software from BD Biosciences (New Jersey, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!